Brandywine Global Investment Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-138,554
Closed -$11.2M 731
2023
Q1
$11.2M Sell
138,554
-15,377
-10% -$1.24M 0.09% 214
2022
Q4
$11.5M Sell
153,931
-9,679
-6% -$689K 0.09% 209
2022
Q3
$10.6M Sell
163,610
-2,652
-2% -$184K 0.1% 189
2022
Q2
$11.5M Sell
166,262
-10,190
-6% -$756K 0.1% 184
2022
Q1
$13.6M Sell
176,452
-7,067
-4% -$508K 0.1% 191
2021
Q4
$14.1M Buy
183,519
+51,713
+39% +$3.8M 0.1% 199
2021
Q3
$9.73M Buy
+131,806
New +$9.88M 0.07% 255
2021
Q2
Sell
-295,358
Closed -$22M 711
2021
Q1
$22M Buy
295,358
+85,701
+41% +$6.51M 0.17% 152
2020
Q4
$15.3M Buy
+209,657
New +$14.8M 0.13% 178

Other funds holding HOLX

Brandywine Global Investment Management's HOLX Position: Q2 2023 in Review

Brandywine Global Investment Management sold out of Hologic (HOLX) in Q2 2023, closing a stake of 138,554 shares — an estimated $11.2M sold.

Brandywine Global Investment Management first reported a position in HOLX in Q4 2020 and held it in 9 quarters. The position peaked at $22M in Q1 2021. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Brandywine Global Investment Management reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Brandywine Global Investment Management sold 138,554 Hologic shares in Q2 2023, an estimated $11.2M.
  • Brandywine Global Investment Management first reported a position in Hologic in Q4 2020 and held it in 9 quarters.
  • Brandywine Global Investment Management's Hologic position peaked at $22M in Q1 2021.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Brandywine Global Investment Management's 13F filing for Q2 2023, filed 11 Aug 2023.